According to this study, the global AI-driven Peptide Drug Discovery Platform market size will reach US$ 1320 million by 2031.
AI-driven Peptide Drug Discovery Platforms are tools that use artificial intelligence (AI) technology to accelerate and optimize the discovery and development process of peptide drugs. These platforms typically combine computational biology, machine learning, deep learning and other technologies to improve the efficiency of identifying, designing, optimizing and validating drug candidate molecules.
The global AI-driven peptide drug R&D market is in a period of rapid growth, with the core driving force coming from the high failure rate of traditional peptide R&D (over 90% elimination rate in the preclinical stage) and the significant advantages of AI technology in reducing costs and increasing efficiency (shortening the early R&D cycle by 50%). North America occupies a dominant position (about 48% market share in 2023), mainly due to the concentration of leading companies such as Insilico Medicine and 厂肠丑谤枚诲颈苍驳别谤 and active biopharmaceutical venture capital; the Asia-Pacific region has the fastest growth rate (CAGR of 29%), thanks to China's "14th Five-Year Plan for Bioeconomic Development" policy support for AI pharmaceuticals and technological breakthroughs by local companies such as Tai Technology. In the sub-sectors, tumor treatment (PDC drug development) and anti-infective drugs (antimicrobial peptide optimization) account for more than 60% of the market share, while metabolic diseases and neurological diseases have become emerging growth poles due to breakthroughs in GLP-1 analogs and blood-brain barrier penetration technology. The challenges faced by the industry are the low clinical conversion rate (only 7% of AI-designed drug candidates enter Phase II clinical trials) and data barriers (data closure of pharmaceutical companies limits model training), but the deepening cooperation between multinational pharmaceutical companies and AI platforms (such as Pfizer and Cyclica jointly developing peptide vaccines) is promoting the openness of the ecosystem. In the future, peptide-nucleic acid conjugates (PepRNA) and AI-driven fully automated laboratories (such as the Strateos cloud-based robotics platform) may reshape the industry's competitive landscape.
The 鈥淎I-driven Peptide Drug Discovery Platform Industry Forecast鈥� looks at past sales and reviews total world AI-driven Peptide Drug Discovery Platform sales in 2024, providing a comprehensive analysis by region and market sector of projected AI-driven Peptide Drug Discovery Platform sales for 2025 through 2031. With AI-driven Peptide Drug Discovery Platform sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AI-driven Peptide Drug Discovery Platform industry.
This Insight Report provides a comprehensive analysis of the global AI-driven Peptide Drug Discovery Platform landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on AI-driven Peptide Drug Discovery Platform portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global AI-driven Peptide Drug Discovery Platform market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI-driven Peptide Drug Discovery Platform and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI-driven Peptide Drug Discovery Platform.
This report presents a comprehensive overview, market shares, and growth opportunities of AI-driven Peptide Drug Discovery Platform market by product type, application, key players and key regions and countries.
Segmentation by Type:
Design and Generation Platform
Screening and Optimization Platform
Data-driven Platform
Others
Segmentation by Application:
Scientific Research
Pharmaceuticals
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Peptilogics
Pepticom Ltd
Menten AI
GUBRA
Creative Peptides
Exscalate
Generate Biomedicines
Receptor.AI
Insilico Medicine
厂肠丑谤枚诲颈苍驳别谤
BenevolentAI
Evotec
PeptiFinder
Xtalpi
Sun Novo
Zonsen Peplib Biotech
Tide Tron Biotech
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global AI-driven Peptide Drug Discovery Platform Market Size (2020-2031)
2.1.2 AI-driven Peptide Drug Discovery Platform Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for AI-driven Peptide Drug Discovery Platform by Country/Region (2020, 2024 & 2031)
2.2 AI-driven Peptide Drug Discovery Platform Segment by Type
2.2.1 Design and Generation Platform
2.2.2 Screening and Optimization Platform
2.2.3 Data-driven Platform
2.2.4 Others
2.3 AI-driven Peptide Drug Discovery Platform Market Size by Type
2.3.1 AI-driven Peptide Drug Discovery Platform Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global AI-driven Peptide Drug Discovery Platform Market Size Market Share by Type (2020-2025)
2.4 AI-driven Peptide Drug Discovery Platform Segment by Application
2.4.1 Scientific Research
2.4.2 Pharmaceuticals
2.5 AI-driven Peptide Drug Discovery Platform Market Size by Application
2.5.1 AI-driven Peptide Drug Discovery Platform Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global AI-driven Peptide Drug Discovery Platform Market Size Market Share by Application (2020-2025)
3 AI-driven Peptide Drug Discovery Platform Market Size by Player
3.1 AI-driven Peptide Drug Discovery Platform Market Size Market Share by Player
3.1.1 Global AI-driven Peptide Drug Discovery Platform Revenue by Player (2020-2025)
3.1.2 Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Player (2020-2025)
3.2 Global AI-driven Peptide Drug Discovery Platform Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AI-driven Peptide Drug Discovery Platform by Region
4.1 AI-driven Peptide Drug Discovery Platform Market Size by Region (2020-2025)
4.2 Global AI-driven Peptide Drug Discovery Platform Annual Revenue by Country/Region (2020-2025)
4.3 Americas AI-driven Peptide Drug Discovery Platform Market Size Growth (2020-2025)
4.4 APAC AI-driven Peptide Drug Discovery Platform Market Size Growth (2020-2025)
4.5 Europe AI-driven Peptide Drug Discovery Platform Market Size Growth (2020-2025)
4.6 Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size Growth (2020-2025)
5 Americas
5.1 Americas AI-driven Peptide Drug Discovery Platform Market Size by Country (2020-2025)
5.2 Americas AI-driven Peptide Drug Discovery Platform Market Size by Type (2020-2025)
5.3 Americas AI-driven Peptide Drug Discovery Platform Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AI-driven Peptide Drug Discovery Platform Market Size by Region (2020-2025)
6.2 APAC AI-driven Peptide Drug Discovery Platform Market Size by Type (2020-2025)
6.3 APAC AI-driven Peptide Drug Discovery Platform Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe AI-driven Peptide Drug Discovery Platform Market Size by Country (2020-2025)
7.2 Europe AI-driven Peptide Drug Discovery Platform Market Size by Type (2020-2025)
7.3 Europe AI-driven Peptide Drug Discovery Platform Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa AI-driven Peptide Drug Discovery Platform by Region (2020-2025)
8.2 Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size by Type (2020-2025)
8.3 Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global AI-driven Peptide Drug Discovery Platform Market Forecast
10.1 Global AI-driven Peptide Drug Discovery Platform Forecast by Region (2026-2031)
10.1.1 Global AI-driven Peptide Drug Discovery Platform Forecast by Region (2026-2031)
10.1.2 Americas AI-driven Peptide Drug Discovery Platform Forecast
10.1.3 APAC AI-driven Peptide Drug Discovery Platform Forecast
10.1.4 Europe AI-driven Peptide Drug Discovery Platform Forecast
10.1.5 Middle East & Africa AI-driven Peptide Drug Discovery Platform Forecast
10.2 Americas AI-driven Peptide Drug Discovery Platform Forecast by Country (2026-2031)
10.2.1 United States Market AI-driven Peptide Drug Discovery Platform Forecast
10.2.2 Canada Market AI-driven Peptide Drug Discovery Platform Forecast
10.2.3 Mexico Market AI-driven Peptide Drug Discovery Platform Forecast
10.2.4 Brazil Market AI-driven Peptide Drug Discovery Platform Forecast
10.3 APAC AI-driven Peptide Drug Discovery Platform Forecast by Region (2026-2031)
10.3.1 China AI-driven Peptide Drug Discovery Platform Market Forecast
10.3.2 Japan Market AI-driven Peptide Drug Discovery Platform Forecast
10.3.3 Korea Market AI-driven Peptide Drug Discovery Platform Forecast
10.3.4 Southeast Asia Market AI-driven Peptide Drug Discovery Platform Forecast
10.3.5 India Market AI-driven Peptide Drug Discovery Platform Forecast
10.3.6 Australia Market AI-driven Peptide Drug Discovery Platform Forecast
10.4 Europe AI-driven Peptide Drug Discovery Platform Forecast by Country (2026-2031)
10.4.1 Germany Market AI-driven Peptide Drug Discovery Platform Forecast
10.4.2 France Market AI-driven Peptide Drug Discovery Platform Forecast
10.4.3 UK Market AI-driven Peptide Drug Discovery Platform Forecast
10.4.4 Italy Market AI-driven Peptide Drug Discovery Platform Forecast
10.4.5 Russia Market AI-driven Peptide Drug Discovery Platform Forecast
10.5 Middle East & Africa AI-driven Peptide Drug Discovery Platform Forecast by Region (2026-2031)
10.5.1 Egypt Market AI-driven Peptide Drug Discovery Platform Forecast
10.5.2 South Africa Market AI-driven Peptide Drug Discovery Platform Forecast
10.5.3 Israel Market AI-driven Peptide Drug Discovery Platform Forecast
10.5.4 Turkey Market AI-driven Peptide Drug Discovery Platform Forecast
10.6 Global AI-driven Peptide Drug Discovery Platform Forecast by Type (2026-2031)
10.7 Global AI-driven Peptide Drug Discovery Platform Forecast by Application (2026-2031)
10.7.1 GCC Countries Market AI-driven Peptide Drug Discovery Platform Forecast
11 Key Players Analysis
11.1 Peptilogics
11.1.1 Peptilogics Company Information
11.1.2 Peptilogics AI-driven Peptide Drug Discovery Platform Product Offered
11.1.3 Peptilogics AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Peptilogics Main Business Overview
11.1.5 Peptilogics Latest Developments
11.2 Pepticom Ltd
11.2.1 Pepticom Ltd Company Information
11.2.2 Pepticom Ltd AI-driven Peptide Drug Discovery Platform Product Offered
11.2.3 Pepticom Ltd AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Pepticom Ltd Main Business Overview
11.2.5 Pepticom Ltd Latest Developments
11.3 Menten AI
11.3.1 Menten AI Company Information
11.3.2 Menten AI AI-driven Peptide Drug Discovery Platform Product Offered
11.3.3 Menten AI AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Menten AI Main Business Overview
11.3.5 Menten AI Latest Developments
11.4 GUBRA
11.4.1 GUBRA Company Information
11.4.2 GUBRA AI-driven Peptide Drug Discovery Platform Product Offered
11.4.3 GUBRA AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 GUBRA Main Business Overview
11.4.5 GUBRA Latest Developments
11.5 Creative Peptides
11.5.1 Creative Peptides Company Information
11.5.2 Creative Peptides AI-driven Peptide Drug Discovery Platform Product Offered
11.5.3 Creative Peptides AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Creative Peptides Main Business Overview
11.5.5 Creative Peptides Latest Developments
11.6 Exscalate
11.6.1 Exscalate Company Information
11.6.2 Exscalate AI-driven Peptide Drug Discovery Platform Product Offered
11.6.3 Exscalate AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Exscalate Main Business Overview
11.6.5 Exscalate Latest Developments
11.7 Generate Biomedicines
11.7.1 Generate Biomedicines Company Information
11.7.2 Generate Biomedicines AI-driven Peptide Drug Discovery Platform Product Offered
11.7.3 Generate Biomedicines AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Generate Biomedicines Main Business Overview
11.7.5 Generate Biomedicines Latest Developments
11.8 Receptor.AI
11.8.1 Receptor.AI Company Information
11.8.2 Receptor.AI AI-driven Peptide Drug Discovery Platform Product Offered
11.8.3 Receptor.AI AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Receptor.AI Main Business Overview
11.8.5 Receptor.AI Latest Developments
11.9 Insilico Medicine
11.9.1 Insilico Medicine Company Information
11.9.2 Insilico Medicine AI-driven Peptide Drug Discovery Platform Product Offered
11.9.3 Insilico Medicine AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Insilico Medicine Main Business Overview
11.9.5 Insilico Medicine Latest Developments
11.10 厂肠丑谤枚诲颈苍驳别谤
11.10.1 厂肠丑谤枚诲颈苍驳别谤 Company Information
11.10.2 厂肠丑谤枚诲颈苍驳别谤 AI-driven Peptide Drug Discovery Platform Product Offered
11.10.3 厂肠丑谤枚诲颈苍驳别谤 AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 厂肠丑谤枚诲颈苍驳别谤 Main Business Overview
11.10.5 厂肠丑谤枚诲颈苍驳别谤 Latest Developments
11.11 BenevolentAI
11.11.1 BenevolentAI Company Information
11.11.2 BenevolentAI AI-driven Peptide Drug Discovery Platform Product Offered
11.11.3 BenevolentAI AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 BenevolentAI Main Business Overview
11.11.5 BenevolentAI Latest Developments
11.12 Evotec
11.12.1 Evotec Company Information
11.12.2 Evotec AI-driven Peptide Drug Discovery Platform Product Offered
11.12.3 Evotec AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Evotec Main Business Overview
11.12.5 Evotec Latest Developments
11.13 PeptiFinder
11.13.1 PeptiFinder Company Information
11.13.2 PeptiFinder AI-driven Peptide Drug Discovery Platform Product Offered
11.13.3 PeptiFinder AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 PeptiFinder Main Business Overview
11.13.5 PeptiFinder Latest Developments
11.14 Xtalpi
11.14.1 Xtalpi Company Information
11.14.2 Xtalpi AI-driven Peptide Drug Discovery Platform Product Offered
11.14.3 Xtalpi AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Xtalpi Main Business Overview
11.14.5 Xtalpi Latest Developments
11.15 Sun Novo
11.15.1 Sun Novo Company Information
11.15.2 Sun Novo AI-driven Peptide Drug Discovery Platform Product Offered
11.15.3 Sun Novo AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Sun Novo Main Business Overview
11.15.5 Sun Novo Latest Developments
11.16 Zonsen Peplib Biotech
11.16.1 Zonsen Peplib Biotech Company Information
11.16.2 Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Product Offered
11.16.3 Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Zonsen Peplib Biotech Main Business Overview
11.16.5 Zonsen Peplib Biotech Latest Developments
11.17 Tide Tron Biotech
11.17.1 Tide Tron Biotech Company Information
11.17.2 Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Product Offered
11.17.3 Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Tide Tron Biotech Main Business Overview
11.17.5 Tide Tron Biotech Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.